Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aveanna Healthcare Holdings (AVAH) Notes Payables (2021 - 2026)

Aveanna Healthcare Holdings' Notes Payables history spans 5 years, with the latest figure at $6.2 million for Q1 2026.

  • For Q1 2026, Notes Payables rose 19.99% year-over-year to $6.2 million; the TTM value through Jan 2026 reached $6.2 million, up 19.99%, while the annual FY2026 figure was $6.2 million, 19.99% up from the prior year.
  • Notes Payables reached $6.2 million in Q1 2026 per AVAH's latest filing, up from $5.2 million in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $6.2 million in Q1 2026 to a low of $4.0 million in Q4 2023.
  • Average Notes Payables over 4 years is $5.3 million, with a median of $5.2 million recorded in 2024.
  • Peak YoY movement for Notes Payables: skyrocketed 77.96% in 2022, then plummeted 35.95% in 2023.
  • A 4-year view of Notes Payables shows it stood at $6.2 million in 2022, then tumbled by 35.95% to $4.0 million in 2023, then skyrocketed by 30.27% to $5.2 million in 2024, then rose by 19.99% to $6.2 million in 2026.
  • Per Business Quant, the three most recent readings for AVAH's Notes Payables are $6.2 million (Q1 2026), $5.2 million (Q4 2024), and $4.0 million (Q4 2023).